411 filings
Page 15 of 21
UPLOAD
887il
7 Feb 20
Letter from SEC
12:00am
F-1
na8sgxrn8qj5r
31 Jan 20
Registration statement (foreign)
12:00am
6-K
sih41re frvsk
22 Jan 20
Current report (foreign)
4:25pm
6-K
ms600irp
8 Jan 20
Report of Foreign Private Issuer
4:14pm
6-K
xpnxrt
2 Jan 20
Report of Foreign Private Issuer
9:31am
6-K
iw1e u6yle
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
424B5
tn0cxcocewc9t rl1a
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
q417zyyaxq7pij
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
avhtfj
3 Dec 19
Current report (foreign)
12:00am
6-K
dgg52nr
26 Nov 19
Report of Foreign Private Issuer
4:01pm
6-K
feh31f0
19 Nov 19
Report of Foreign Private Issuer
8:33am
6-K
qmmu9 6omxhef
13 Nov 19
Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program
4:07pm
6-K
x9gsll8xgrl unm8
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
0j2j0mj7p
15 Oct 19
Therapix Biosciences Announces Positive Data From Recent Pre-Clinical Study for New Drug Candidate THX-210
4:10pm
6-K
xbzr 3kbvg
11 Oct 19
Current Report of Foreign Issuer
12:00am
EFFECT
wg71riw2p 6xl
6 Sep 19
Notice of effectiveness
12:15am
CORRESP
dh98 6nbcy
3 Sep 19
Correspondence with SEC
12:00am
F-3/A
n0rpils3tw s3uwbnf4
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
CORRESP
zo7httvhv7th3td7p43n
29 Aug 19
Correspondence with SEC
12:00am
6-K
wf3zb8u
27 Aug 19
Current report (foreign)
4:13pm